Merck drug Keytruda succeeds in late-stage esophageal cancer trial

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 66%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

Merck cancer drug Keytruda succeeds in late-stage trial

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Merck loses bid to revive US$200 million Gilead verdict at US high courtThe U.S. Supreme Court on Monday handed a defeat to Merck & Co by refusing to hear its appeal of a ruling that it had dishonestly obtained patent ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

US Supreme Court could side with Merck over Fosamax lawsuitsU.S. Supreme Court justices on Monday appeared sympathetic to Merck & Co in its bid to fend off hundreds of lawsuits accusing the company of ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

JNJ-AbbVie cancer drug Imbruvica succeeds in late-stage trialREUTERS: Johnson and Johnson said on Tuesday a combination therapy containing its blockbuster cancer drug Imbruvica significantly improved ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

AbbVie halts late-stage trial for lung cancer drug Rova-TREUTERS: AbbVie said on Wednesday it had halted enrollment for a late stage trial of Rova-T as a second-line therapy for advanced small-cell lung ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Bristol-Myers Squibb says cancer drug combination fails late-stage trialBristol-Myers Squibb Co said on Monday a combination of two of its cancer drugs, being tested as a maintenance therapy, did not meet the main goal ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

AstraZeneca's pivotal lung cancer trial fails main goal in late stage trialAstraZeneca's combination of two immunotherapy drugs did not meet the main goal in a closely watched late stage study, the company said on Friday.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »